INSIDERTERMINAL

High-Impact Form 4 Intelligence

Real-time SEC insider trading data with advanced filtering. Free beta.

💬 Give Feedback

Total Buys (Filtered)

$86K

$86,588

Total Sells (Filtered)

$474K

$474,414

View Combined Trades

Live Feed: 2026-03-11

Timeline

Side

Size

All $1M+ $5M+ $10M+

Role

Ticker Search

Clear Clear Filters

Ticker	Company	Reporting Owner	Date	Value (USD)	Type	Form 4
AKBA P Akebia Therapeutics, Inc. Butler John P. • CEO Discretionary Buy 2026-03-04 $86,588 View Form 4 →
AKBA	Akebia Therapeutics, Inc.	Butler John P. CEO Discretionary Buy	2026-03-04	$86,588	P	Form 4
AKBA S Akebia Therapeutics, Inc. Butler John P. • CEO Sell to Cover 2026-02-02 $64,857 View Form 4 →
AKBA	Akebia Therapeutics, Inc.	Butler John P. CEO Sell to Cover	2026-02-02	$64,857	S	Form 4
AKBA S Akebia Therapeutics, Inc. Butler John P. • CEO Sell to Cover 2026-02-02 $133,530 View Form 4 →
AKBA	Akebia Therapeutics, Inc.	Butler John P. CEO Sell to Cover	2026-02-02	$133,530	S	Form 4
AKBA S Akebia Therapeutics, Inc. Butler John P. • CEO Sell to Cover 2026-02-02 $159,698 View Form 4 →
AKBA	Akebia Therapeutics, Inc.	Butler John P. CEO Sell to Cover	2026-02-02	$159,698	S	Form 4
AKBA S Akebia Therapeutics, Inc. Butler John P. • CEO Sell to Cover 2026-02-02 $116,328 View Form 4 →
AKBA	Akebia Therapeutics, Inc.	Butler John P. CEO Sell to Cover	2026-02-02	$116,328	S	Form 4